SureTrader
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 4/16/2018 6:02:00 PM - Followers: 33 - Board type: Free - Posts Today: 0
SureTrader
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
BMY News: U.S. Food & Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treat... 04/18/2018 04:15:00 PM
BMY News: Bristol-Myers Squibb Announces Worldwide Collaboration with Janssen to Develop & Commercialize Next-Generation Cardiovascular... 04/16/2018 04:15:00 PM
BMY News: In CheckMate -141, Opdivo (nivolumab) Demonstrated Sustained Overall Survival (OS) Advantage over Standard of Care in Patient... 04/16/2018 04:03:00 PM
BMY News: U.S. Food & Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) Combination as First-Line Treatment for... 04/16/2018 12:52:00 PM
BMY News: Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death by 42% Versus Chemotherapy in First-Line Lun... 04/16/2018 09:05:00 AM
News News Alert: U.S. Food & Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treat... 04/18/2018 04:15:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#748  Sticky Note BMY, NKTR ink global collaboration for NKTR-214: DewDiligence 02/14/18 08:16:41 AM
#767   BMY AACR-webcast slides: DewDiligence 04/16/18 06:02:00 PM
#766   BMY, JNJ ink collaboration to develop/commercialize BMS-986177: #msg-140083631. DewDiligence 04/16/18 04:57:25 PM
#765   Anyone buying BMY on the plunge? $1.60 dividend biotech_researcher 04/16/18 02:21:42 PM
#764   FDA approves Opdivo/Yervoy combo in first-line RCC: DewDiligence 04/16/18 01:17:08 PM
#763   CHECKMATE-227 study in NSCLC disappoints: #msg-140073655. DewDiligence 04/16/18 12:12:19 PM
#761   Lung cancer battle brews Lung cancer drug trial data biotech_researcher 04/14/18 04:06:57 PM
#760   Bristol Myers Squibb $BMY Tests Key Level, Here ITMS 04/12/18 12:09:52 PM
#759   BMY -3% on this blurb re PFE’s (lack DewDiligence 04/12/18 09:39:55 AM
#758   MRK +6%; BMY -1% on Keytruda KEYNOTE-042 results: #msg-139894079. DewDiligence 04/09/18 12:02:18 PM
#757   NKTR-214 JV clears HSR review—BMY can now start DewDiligence 04/04/18 01:32:16 PM
#756   True. But there is the upcoming Johnny_C 03/19/18 04:01:15 PM
#755   BMY's 1Q17 CC is back to the usual DewDiligence 03/14/18 09:51:29 AM
#754   Take 2 on BMY reporting before PFE. Johnny_C 03/14/18 09:23:25 AM
#753   FDA approves Opdivo monthly dosing and shorter infusion time: DewDiligence 03/06/18 11:42:51 AM
#751   Re: PFE-BMY DewDiligence 02/24/18 01:48:52 PM
#750   Very Good deal for NKTR though, and utimately Johnny_C 02/15/18 04:32:56 PM
#749   Tiny Deal... Want some big news.... The PFE Johnny_C 02/15/18 09:16:40 AM
#748   BMY, NKTR ink global collaboration for NKTR-214: DewDiligence 02/14/18 08:16:41 AM
#747   This Leading Pharma Stock Breaks Its 200-Day Moving Average ITMS 02/06/18 11:54:22 AM
#746   (Revised)—Musings on CHECKMATE-227 results: #msg-138300300. DewDiligence 02/05/18 06:29:45 PM
#744   We appreciate our portfolio gain in BMY this north40000 02/05/18 10:00:52 AM
#743   BMY 4Q17 results /CHECKMATE-227 results: DewDiligence 02/05/18 08:08:54 AM
#741   Not just one bet my friend, only profitable Johnny_C 02/02/18 09:02:10 AM
#740   Simpler explanation: a bet that didn't pan out. DrZem 01/31/18 07:34:16 PM
#739   Argggg. Looks like there was nothing to Johnny_C 01/31/18 05:40:14 PM
#738   Wow. Bmy Options flying. Pfe traded Johnny_C 01/26/18 04:24:56 PM
#737   With all the buyout action happening BMY is Johnny_C 01/24/18 08:19:54 AM
#735   Interesting news on Keytruda. Celgene making another potential Johnny_C 01/17/18 07:28:19 AM
#734   BMY -2% on Keytruda news: #msg-137706298. DewDiligence 01/16/18 09:34:54 AM
#733   True, got a little burst at close. Some Johnny_C 01/11/18 04:06:55 PM
#732   The mystery wrt the 4Q17 CC schedule remains. DewDiligence 01/10/18 03:53:09 PM
#731   The transcript is really a love fest with Johnny_C 01/10/18 03:48:52 PM
#730   BMY JPM slides: DewDiligence 01/09/18 12:17:10 PM
#729   Here's Hoping.... otherwise I am down a 2018 Johnny_C 12/27/17 11:39:47 AM
#728   PFE has reported after BMY every quarter during DewDiligence 12/27/17 10:52:27 AM
#727   PFE earnings the 30th. Usually they are Johnny_C 12/27/17 10:46:30 AM
#726   Roger that :) Mostly invested Johnny_C 12/19/17 01:49:38 PM
#725   LOL, that's pretty funny. DewDiligence 12/19/17 01:07:27 PM
#724   I thought that tweet was funny so I Johnny_C 12/19/17 01:03:15 PM
#723   I consider pharma/biotech to be one industry. My DewDiligence 12/19/17 12:57:23 PM
#722   Thanks, I love conspiracies... After having big win Johnny_C 12/19/17 12:50:25 PM
#721   https://twitter.com/DewDiligence/status/943168656422375424 :- ) DewDiligence 12/19/17 12:19:47 PM
#720   Feb 5 earnings call. Will certainly be intersting Johnny_C 12/19/17 12:10:38 PM
#719   https://www.fiercepharma.com/marketing/pfizer-bms-eliquis-takes-j-j-s-next-gen-anticoagulant-market- Johnny_C 12/18/17 04:34:50 PM
#718   I know... Even if a mega deal was Johnny_C 12/18/17 01:58:37 PM
#717   PFE's $10B buyback is just an authorization—there is DewDiligence 12/18/17 01:51:29 PM
#716   BMY and PFE raising dividends, PFE doing a Johnny_C 12/18/17 01:13:06 PM
#715   Looks like big Pharma / multi nationals have DewDiligence 12/18/17 09:35:45 AM
#714   Looks like big Pharma / multi nationals have Johnny_C 12/18/17 08:59:38 AM
#713   Sabby Management has a ton of BMY, as Johnny_C 12/14/17 07:56:20 PM
PostSubject